Sign in
Pediatric Infectious Diseases Physicians' Preferences for Management of Clostridioides difficile Infection: An Emerging Infections Network (EIN) Survey
Journal article

Pediatric Infectious Diseases Physicians' Preferences for Management of Clostridioides difficile Infection: An Emerging Infections Network (EIN) Survey

Alexandra Linn, Noah Boton, Susan E Beekmann, Larry Kociolek, Thomas J Sandora, Philip M Polgreen, Matthew S L Lee and Preeti Mehrotra
Journal of the Pediatric Infectious Diseases Society, Vol.15(1), piag004
01/19/2026
DOI: 10.1093/jpids/piag004
PMID: 41553256

View Online

Abstract

We queried pediatric infectious diseases physicians via the Emerging Infections Network regarding management preferences for Clostridioides difficile infection (CDI). We explored use of vancomycin, fidaxomicin, bezlotoxumab and fecal microbiota transplantation and found that physicians are increasingly considering newer and adjunctive therapies for pediatric CDI, highlighting the need for updated guidelines.
Clostridioides difficile Management fecal microbiota transplantation fidaxomicin

Details

Metrics

1 Record Views
Logo image